EPG Wealth Management’s Arthur J. Gallagher & Co AJG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Sell
5,012
-106
-2% -$22.5K 0.28% 88
2026
Q1
$1.11M Buy
5,118
+42
+0.8% +$9.7K 0.3% 90
2025
Q4
$1.31M Buy
5,076
+191
+4% +$50.6K 0.35% 78
2025
Q3
$1.51M Buy
4,885
+283
+6% +$85.3K 0.42% 66
2025
Q2
$1.47M Buy
4,602
+104
+2% +$34.3K 0.44% 62
2025
Q1
$1.55M Buy
4,498
+314
+8% +$99.2K 0.43% 63
2024
Q4
$1.19M Sell
4,184
-35
-0.8% -$10.2K 0.31% 88
2024
Q3
$1.19M Buy
+4,219
New +$1.19M 0.3% 92
2024
Q2
Sell
-4,061
Closed -$1.01M 99
2024
Q1
$1.02M Buy
4,061
+33
+0.8% +$7.93K 0.25% 103
2023
Q4
$952K Buy
4,028
+223
+6% +$52.8K 0.25% 101
2023
Q3
$867K Buy
3,805
+378
+11% +$84.6K 0.26% 96
2023
Q2
$752K Buy
3,427
+278
+9% +$57.9K 0.22% 110
2023
Q1
$602K Buy
+3,149
New +$597K 0.19% 125

Other funds holding AJG

EPG Wealth Management's AJG Position: Q2 2026 in Review

EPG Wealth Management reduced its Arthur J. Gallagher & Co (AJG) stake by 2.1% in Q2 2026, selling an estimated $22.5K and leaving 5,012 shares worth $1.15M. The position accounts for 0.28% of the portfolio, ranked #88.

EPG Wealth Management first reported a position in AJG in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.55M in Q1 2025. 1,285 funds tracked by Wall St. Rank hold AJG as of Q2 2026.

  • EPG Wealth Management held 5,012 shares of Arthur J. Gallagher & Co worth $1.15M as of Q2 2026.
  • EPG Wealth Management sold 106 Arthur J. Gallagher & Co shares in Q2 2026, an estimated $22.5K.
  • Arthur J. Gallagher & Co made up 0.28% of EPG Wealth Management's portfolio in Q2 2026, its #88 holding.
  • EPG Wealth Management first reported a position in Arthur J. Gallagher & Co in Q1 2023 and has held it in 13 quarters since.
  • EPG Wealth Management's Arthur J. Gallagher & Co position peaked at $1.55M in Q1 2025.
  • 1,285 funds tracked by Wall St. Rank held Arthur J. Gallagher & Co as of Q2 2026.

Based on EPG Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.